Journal of gynecologic oncology

Keyphrases

Publications

volume 35, number 4, 2024

Tae Wook Kong, Jayoun Kim, Junghoe Kim, Jimin Lee, Jeeyeon Kim, Joo Hyuk Son, Suk-Joon Chang
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients. Journal of gynecologic oncology 35 (4) (2024)
Atsushi Fusegi, Hiroyuki Kanao, Mayumi Kamata, Shogo Nishino, Akiko Abe, Makiko Omi, Hidetaka Nomura
Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy. Journal of gynecologic oncology 35 (4) (2024)
Yoshifumi Takahashi, Hiroyuki Fujiwara, Kouji Yamamoto, Masashi Takano, Morikazu Miyamoto, Kosei Hasegawa, Maiko Miwa, Toyomi Satoh, Hiroya Itagaki, Takashi Hirakawa, Mayuyo Mori-Uchino, Tomonori Nagai, Yoshinobu Hamada, Soichi Yamashita, Hiroko Yano, Tomoyasu Kato, Keiichi Fujiwara, Mitsuaki Suzuki, null null
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial. Journal of gynecologic oncology 35 (4) (2024)
Kewei Zheng, Yi Gao, Cong-Jian Xu, Yu Kang
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis. Journal of gynecologic oncology 35 (4) (2024)
Hyun Woong Cho, Sohyeon Jeong, Seung Hun Song, Young-Tae Kim, Jae-Weon Kim, Chi Heum Cho, Soo Young Hur, Suk-Joon Chang, Yong-Man Kim, Jae Kwan Lee
A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2. Journal of gynecologic oncology 35 (4) (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
Eun-Jung Yang, Seung-Hyuk Shim
Response to: Author's reply to: Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study. Journal of gynecologic oncology 35 (4) (2024)
Xiyao Yin, Xin Liu, Hui Gong, Zhiliang Chu
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling. Journal of gynecologic oncology 35 (4) (2024)
Eun-Jung Yang, A-Jin Lee, Yong Beom Kim, Suk-Joon Chang, Hee Seung Kim, Nam Kyeong Kim, Yeorae Kim, Tae Wook Kong, Eun Ji Lee, Soo Jin Park, Joo Hyuk Son, Dong Hoon Suh, Dong Hee Son, Seung-Hyuk Shim
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study. Journal of gynecologic oncology 35 (4) (2024)
Hyun Woong Cho, Sohyeon Jeong, Seung Hun Song, Young-Tae Kim, Jae-Weon Kim, Chi Heum Cho, Soo Young Hur, Suk-Joon Chang, Yong-Man Kim, Jae Kwan Lee
A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2. Journal of gynecologic oncology 35 (4) (2024)
Chiara Perrone, Roberto Angioli, Daniela Luvero, Andrea Giannini, Violante Di Donato, Ilaria Cuccu, Ludovico Muzii, Francesco Raspagliesi, Giorgio Bogani
Targeting BRAF pathway in low-grade serous ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Chenlian Quan, Zhong Zheng, Siyu Cao, Yong Wu, Wei Zhang, Yan Huang
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of gynecologic oncology 35 (4) (2024)
Xiyao Yin, Xin Liu, Hui Gong, Zhiliang Chu
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling. Journal of gynecologic oncology 35 (4) (2024)
Atsushi Fusegi, Hiroyuki Kanao, Mayumi Kamata, Shogo Nishino, Akiko Abe, Makiko Omi, Hidetaka Nomura
Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy. Journal of gynecologic oncology 35 (4) (2024)
Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri, Erin Bishop, Anita Chudecka-Głaz, Alix Devaux, Laurence Gladieff, Mary E Gordinier, Jacob Korach, Michael E McCollum, Linda R Mileshkin, Bradley J Monk, Shibani Nicum, Angélica N Rodrigues, Ana Oaknin, David M O'Malley, Mauro Orlando, Lyndah Dreiling, Iulia C Tudor, Domenica Lorusso
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Hineptch Daungsupawong, Rujittika Mungmunpuntipantip
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis: comment. Journal of gynecologic oncology 35 (4) (2024)
Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study. Journal of gynecologic oncology 35 (4) (2024)
Xingchen Li, Yiqin Wang, Jiaqi Wang, Jingyi Zhou, Jianliu Wang
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma. Journal of gynecologic oncology 35 (4) (2024)
Aditi Bhatt, Snita Sinukumar, Dileep Damodaran, Loma Parikh, Gaurav Goswami, Sanket Mehta, Praveen Kammar
Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study. Journal of gynecologic oncology 35 (4) (2024)
Chiara Perrone, Roberto Angioli, Daniela Luvero, Andrea Giannini, Violante Di Donato, Ilaria Cuccu, Ludovico Muzii, Francesco Raspagliesi, Giorgio Bogani
Targeting BRAF pathway in low-grade serous ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Fatma Ferda Verit, Tugan Beşe, Fuat Demirkiran
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al. Journal of gynecologic oncology 35 (4) (2024)
Xingchen Li, Yiqin Wang, Jiaqi Wang, Jingyi Zhou, Jianliu Wang
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma. Journal of gynecologic oncology 35 (4) (2024)
Atsushi Fusegi, Hiroyuki Kanao, Mayumi Kamata, Shogo Nishino, Akiko Abe, Makiko Omi, Hidetaka Nomura
Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy. Journal of gynecologic oncology 35 (4) (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
Fatma Ferda Verit, Tugan Beşe, Fuat Demirkiran
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al. Journal of gynecologic oncology 35 (4) (2024)
Chinmoy K Bose, Nirban Basu
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Aditi Bhatt, Snita Sinukumar, Dileep Damodaran, Loma Parikh, Gaurav Goswami, Sanket Mehta, Praveen Kammar
Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study. Journal of gynecologic oncology 35 (4) (2024)
R Wendel Naumann
The SHAPE trial: is good is good enough? Journal of gynecologic oncology 35 (4) (2024)
Eun-Jung Yang, A-Jin Lee, Yong Beom Kim, Suk-Joon Chang, Hee Seung Kim, Nam Kyeong Kim, Yeorae Kim, Tae Wook Kong, Eun Ji Lee, Soo Jin Park, Joo Hyuk Son, Dong Hoon Suh, Dong Hee Son, Seung-Hyuk Shim
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study. Journal of gynecologic oncology 35 (4) (2024)
Hineptch Daungsupawong, Rujittika Mungmunpuntipantip
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis: comment. Journal of gynecologic oncology 35 (4) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Tae Wook Kong, Jayoun Kim, Junghoe Kim, Jimin Lee, Jeeyeon Kim, Joo Hyuk Son, Suk-Joon Chang
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients. Journal of gynecologic oncology 35 (4) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Yoshifumi Takahashi, Hiroyuki Fujiwara, Kouji Yamamoto, Masashi Takano, Morikazu Miyamoto, Kosei Hasegawa, Maiko Miwa, Toyomi Satoh, Hiroya Itagaki, Takashi Hirakawa, Mayuyo Mori-Uchino, Tomonori Nagai, Yoshinobu Hamada, Soichi Yamashita, Hiroko Yano, Tomoyasu Kato, Keiichi Fujiwara, Mitsuaki Suzuki, null null
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial. Journal of gynecologic oncology 35 (4) (2024)
Xingchen Li, Yiqin Wang, Jiaqi Wang, Jingyi Zhou, Jianliu Wang
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma. Journal of gynecologic oncology 35 (4) (2024)
Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Ling-Ying Wu, Hongwen Yao
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 35 (4) (2024)
R Wendel Naumann
The SHAPE trial: is good is good enough? Journal of gynecologic oncology 35 (4) (2024)
Takeshi Makabe, Wataru Yamagami, Fumiaki Takahashi, Hideki Tokunaga, Eiko Yamamoto, Yoshihito Yokoyama, Kiyoshi Yoshino, Kei Kawana, Satoru Nagase
Detailed report on the clinicopathological factors of patients with endometrial cancer in Japan: a JSOG gynecologic tumor registry-based study. Journal of gynecologic oncology 35 (4) (2024)
Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi, Akiko Abe, Hidetaka Nomura, Hiroyuki Kanao
Cerebral infarction caused by Trousseau syndrome associated with cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Kewei Zheng, Yi Gao, Cong-Jian Xu, Yu Kang
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis. Journal of gynecologic oncology 35 (4) (2024)
Chenlian Quan, Zhong Zheng, Siyu Cao, Yong Wu, Wei Zhang, Yan Huang
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of gynecologic oncology 35 (4) (2024)
Yoshifumi Takahashi, Hiroyuki Fujiwara, Kouji Yamamoto, Masashi Takano, Morikazu Miyamoto, Kosei Hasegawa, Maiko Miwa, Toyomi Satoh, Hiroya Itagaki, Takashi Hirakawa, Mayuyo Mori-Uchino, Tomonori Nagai, Yoshinobu Hamada, Soichi Yamashita, Hiroko Yano, Tomoyasu Kato, Keiichi Fujiwara, Mitsuaki Suzuki, null null
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial. Journal of gynecologic oncology 35 (4) (2024)
Eun-Jung Yang, A-Jin Lee, Yong Beom Kim, Suk-Joon Chang, Hee Seung Kim, Nam Kyeong Kim, Yeorae Kim, Tae Wook Kong, Eun Ji Lee, Soo Jin Park, Joo Hyuk Son, Dong Hoon Suh, Dong Hee Son, Seung-Hyuk Shim
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study. Journal of gynecologic oncology 35 (4) (2024)
Hyun Woong Cho, Sohyeon Jeong, Seung Hun Song, Young-Tae Kim, Jae-Weon Kim, Chi Heum Cho, Soo Young Hur, Suk-Joon Chang, Yong-Man Kim, Jae Kwan Lee
A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2. Journal of gynecologic oncology 35 (4) (2024)
Chinmoy K Bose, Nirban Basu
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer. Journal of gynecologic oncology 35 (4) (2024)
Tae Wook Kong, Jayoun Kim, Junghoe Kim, Jimin Lee, Jeeyeon Kim, Joo Hyuk Son, Suk-Joon Chang
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients. Journal of gynecologic oncology 35 (4) (2024)

volume 35, number 5, 2024